Web Chapter 53 Hepatic Support Therapy

  1. Center SA et al: Evaluation of the influence of S–adenosylmethionine on systemic and hepatic effects of prednisolone in dogs, Am J Vet Res 66:330, 2005. PUBMED Abstract
  2. Center SA, Warner KL, Erb HN: Liver glutathione concentrations in dogs and cat with naturally occurring liver disease, Am J Vet Res 63:1187, 2002. PUBMED Abstract
  3. Honeckman A: Current concepts in the treatment of canine chronic hepatitis, Clin Tech Small Anim Pract 18:239, 2003. PUBMED Abstract
  4. Matthai J: Vitamin E updated, Indian J Pediatr 63:42, 1996. PUBMED Abstract
  5. Miller ER et al: Meta-analysis: high-dosage vitamin E supplementation may increase all-cause mortality, Ann Intern Med 142:37, 2005. PUBMED Abstract
  6. Munshi MK et al: The role of the renin-angiotensin system in liver fibrosis, Exp Biol Med 236:557, 2011. PUBMED Abstract
  7. Rambaldi A et al: Colchicine for alcoholic and non-alcoholic liver fibrosis and cirrhosis, Cochrane Database Syst Rev 3:CD002148, 2001. PUBMED Abstract
  8. Rocky DC: Antifibrotic therapy in chronic liver disease, Clin Gastroenterol Hepatol 3:95, 2005.
  9. Rothuizen J et al, editors: WSAVA standards for clinical and histological diagnosis of canine and feline liver diseases, Edinburgh, 2006, Saunders/Elsevier.
  10. Seeff LB et al: Complementary and alternative medicine in chronic liver disease, Hepatology 34:595, 2001. PUBMED Abstract
  11. Skorupski KA et al: Prospective randomized clinical trial assessing the efficacy of Denamarin for prevention of CCNU-induced hepatopathy in tumor-bearing dogs, J Vet Intern Med 25:838, 2011. PUBMED Abstract
  12. Webb CB et al: Bioavailability following oral administration of a silibinin-phosphatidylcholine complex in cats, Intern J Appl Vet Med 10:107, 2012.
  13. Webster CRL: History, clinical signs, and physical findings in hepatobiliary disease. In Ettinger SJ, Feldman EC, editors: Textbook of veterinary internal medicine, ed 6, St Louis, 2005, Elsevier, p 1422.